Hui Cong

2.7k citations
97 papers · 2.1k · h-index 26

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Cancer Genomics and Diagnostics
    • Circular RNAs in diseases
    • Advanced biosensing and bioanalysis techniques
    • RNA modifications and cancer
    • Metabolomics and Mass Spectrometry Studies

Papers in

    • Circular RNAs in diseases 14
    • RNA modifications and cancer 6
    • MicroRNA in disease regulation 17
    • Cancer-related molecular mechanisms research 15
    • Cancer Genomics and Diagnostics 9

Hui Cong

91 papers receiving 2.1k citations

Peers

Hui Cong
Comparison fields: 5 of 111
  • Cancer Research 725
  • Molecular Biology 1.2k
  • Oncology 354
  • Biomedical Engineering 336
  • Hematology 77
Replace Sung-Gil Chi with:
Sung-Gil Chi South Korea
Michael H. Muders Germany
Qiong Wu China
Francesco� Fabbri Italy
Xin Xu China
Kristina Viktorsson Sweden
Min Luo China
Jiang Yang United States
Jianghong Deng China
Hui Cong relative to Sung-Gil Chi South Korea Sung-Gil Chi's profile →
Citations per field
00.5×1.5×1.8×
Sung-Gil Chi · 1×
Citations per year

Countries citing papers authored by Hui Cong

Since Specialization
Citations

This map shows the geographic impact of Hui Cong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Cong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Cong more than expected).

Fields of papers citing papers by Hui Cong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Cong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Cong. The network helps show where Hui Cong may publish in the future.

Co-authors

The 25 scholars most cited alongside Hui Cong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hui Cong Line = papers co-authored together Hui Cong links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2009170
2 2018150
3 201694
4 201989
5 201385
6 201984
7 201767
8 201562
9 200260
10 201658
11 201648
12 201846
13 201643
14 201943
15 201941
16 201239
17 201937
18 202035
19 201835
20
Diminished LINC00173 expression induced miR-182-5p accumulation promotes cell proliferation, migration and apoptosis inhibition via AGER/NF-κB pathway in non-small-cell lung cancer.
201934

About Hui Cong

Hui Cong is a scholar working on Molecular Biology, Cancer Research, Oncology, Biomedical Engineering and Pathology and Forensic Medicine, having authored 97 papers that have together received 2.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (14 papers), Cancer Cells and Metastasis (10 papers), Cancer Genomics and Diagnostics (9 papers), Microfluidic and Bio-sensing Technologies (8 papers), Microfluidic and Capillary Electrophoresis Applications (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (725 citations), Molecular Biology (1.2k citations), Oncology (354 citations), Biomedical Engineering (336 citations) and Hematology (77 citations). Hui Cong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xianjuan Shen, Shaoqing Ju, Chunlin Zhuang, Wannian Zhang, Zhenyuan Miao, Shaoqing Ju, Rongrong Jing, Xudong Wang, Hao Ma and Chunping Jia. Their work appears in journals such as Biosensors and Bioelectronics, Oncotarget, Cancer Biomarkers, Journal of Clinical Laboratory Analysis and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact